. Author manuscript; available in PMC: 2013 Dec 1.

Published in final edited form as: Breast Cancer Res Treat. 2013 Apr 30;139(2):461–468. doi: 10.1007/s10549-013-2546-6

Table 2a.

Prior known associations with breast cancer.

	rs #		AA Counts Case/Control	AA HR (CI)	AA P	AA r^2	Hisp Counts Case/Control	Hisp HR (CI)	Hisp P	Hisp r^2	Meta HR	Meta P

adipor1	rs7539542	GG	128/126	1	---	0.88	63/61	1	---	0.89	1	---
		GC	170/172	0.96 (0.80, 1.15)	0.66		154/164	0.84 (0.55, 1.28)	0.41		0.94 (0.79, 1.11)	0.47
		CC	63/63	0.97 (0.77, 1.24)	0.83		144/137	0.94 (0.62, 1.42)	0.75		0.97 (0.79, 1.19)	0.74

adipoq	rs2241766	TT	330/330	1	---	0.97	259/252	1	---	0.99	1	---
		TG	34/35	0.98 (0.75, 1.27)	0.87		98/104	0.91 (0.66, 1.24)	0.53		0.95 (0.78, 1.16)	0.61
		GG	2/1	2.58 (0.81, 8.25)	0.10		9/10	0.83 (0.34, 2.04)	0.69		1.27 (0.63, 1.6)	0.51

adipoq	rs1501299	TT	37/46	1	---	0.99	24/28	1	---	1	1	---
		TG	157/168	1.18 (0.91, 1.54)	0.60		143/153	1.012 (0.57, 1.79)	0.97		1.15 (0.91, 1.46)	0.25
		GG	172/152	1.41 (1.084, 1.83)	0.010		199/185	1.16 (0.66, 2.02)	0.21		1.36 (1.073, 1.72)	0.011

AA: African American women; Hisp: Hispanic women; Allele: Allele 1/Allele 2; AF Allele frequency of Allele 1; HR: Hazards ratio; CI: confidence interval; Meta: Meta-analysis; r²: Estimated imputation r².